Your browser doesn't support javascript.
loading
Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy.
Weber, Walter Paul; Shaw, Jane; Pusic, Andrea; Wyld, Lynda; Morrow, Monica; King, Tari; Mátrai, Zoltán; Heil, Jörg; Fitzal, Florian; Potter, Shelley; Rubio, Isabel T; Cardoso, Maria-Joao; Gentilini, Oreste Davide; Galimberti, Viviana; Sacchini, Virgilio; Rutgers, Emiel J T; Benson, John; Allweis, Tanir M; Haug, Martin; Paulinelli, Regis R; Kovacs, Tibor; Harder, Yves; Gulluoglu, Bahadir M; Gonzalez, Eduardo; Faridi, Andree; Elder, Elisabeth; Dubsky, Peter; Blohmer, Jens-Uwe; Bjelic-Radisic, Vesna; Barry, Mitchel; Hay, Susanne Dieroff; Bowles, Kimberly; French, James; Reitsamer, Roland; Koller, Rupert; Schrenk, Peter; Kauer-Dorner, Daniela; Biazus, Jorge; Brenelli, Fabricio; Letzkus, Jaime; Saccilotto, Ramon; Joukainen, Sarianna; Kauhanen, Susanna; Karhunen-Enckell, Ulla; Hoffmann, Juergen; Kneser, Ulrich; Kühn, Thorsten; Kontos, Michalis; Tampaki, Ekaterini Christina; Carmon, Moshe.
Afiliación
  • Weber WP; Breast Center, University Hospital Basel, Basel, Switzerland; University of Basel, Basel, Switzerland. Electronic address: walter.weber@usb.ch.
  • Shaw J; Patient Advocacy Group, Oncoplastic Breast Consortium, Basel, Switzerland.
  • Pusic A; Brigham and Women's/Dana Farber Cancer Center, USA.
  • Wyld L; Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
  • Morrow M; Breast Surgery Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • King T; Department of Surgery, Brigham and Women's Hospital / Dana Farber Cancer Institute, USA.
  • Mátrai Z; Department of Breast and Sarcoma Surgery, National Institute of Oncology, Budapest, Hungary.
  • Heil J; Department of Obstetrics and Gynecology, University of Heidelberg, Medical School, Heidelberg, Germany.
  • Fitzal F; Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Potter S; Bristol Centre for Surgical Research, Bristol Medical School, University of Bristol, Clifton, Bristol, UK.
  • Rubio IT; Breast Surgical Oncology, Clinica Universidad de Navarra, Madrid, Spain.
  • Cardoso MJ; Breast Unit, Champalimaud Clinical Centre, Champalimaud Foundation, And Nova Medical School, Lisbon, Portugal.
  • Gentilini OD; IRCCS Ospedale San Raffaele, Milan, Italy.
  • Galimberti V; Istituto Europeo di Oncologia, IRCCS, Milan, Italy.
  • Sacchini V; Breast Surgery Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Rutgers EJT; Department of Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Benson J; Cambridge Breast Unit, Addenbrooke's Hospital Cambridge, Cambridge, UK; Cambridge Breast Unit, Cambridge University Hospitals NHS Foundation TRUST, School of Medicine, Anglia Ruskin University, Cambridge, UK.
  • Allweis TM; Hadassah Medical Center & Faculty of Medicine, Hebrew University, Jerusalem, Israel.
  • Haug M; Breast Center and Department of Plastic, Reconstructive, Aesthetic and Handsurgery University Hospital Basel, University of Basel, Basel, Switzerland.
  • Paulinelli RR; Federal University of Goiás, Araújo Jorge Hospital, Goiás Anti-Cancer Association, Goiás, Brazil.
  • Kovacs T; Jiahui Internatioonal Hospital Shanghai, China; Guy's and St. Thomas' NHS Foundation Trust London, UK.
  • Harder Y; Department of Plastic, Reconstructive and Aesthetic Surgery, Ospedale Regionale di Lugano, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland; Faculty of Biomedical Sciences, Università Della Svizzera Italiana, Lugano, Switzerland.
  • Gulluoglu BM; Marmara University School of Medicine, Istanbul, Turkey.
  • Gonzalez E; Departament of Mastology, Breast Unit- Instituto de Oncología Angel H Roffo, Buenos Aires Univesity. Buenos Aires, Argentina.
  • Faridi A; Department of Senology/Breast Center, University Hospital Bonn, Germany.
  • Elder E; Westmead Breast Cancer Institute, Westmead Hospital, University of Sydney, Australia.
  • Dubsky P; Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Breast Center, Hirslanden Clinic St. Anna, Lucerne, Switzerland.
  • Blohmer JU; Department of Gynecology and Breast Center, Charité University Hospital, Berlin, Germany.
  • Bjelic-Radisic V; Breast Unit, Helios University Hospital, University Witten/Herdecke, Wuppertal, Germany.
  • Barry M; Mater Misericordiae University Hospital, Dublin, Ireland.
  • Hay SD; Patient Advocacy Group, Oncoplastic Breast Consortium, President, the Swedish Breast Cancer Association, Stockholm, Sweden.
  • Bowles K; Patient Advocacy Group, Oncoplastic Breast Consortium, Not Putting on A Shirt, Pittsburgh, USA.
  • French J; Westmead Breast Cancer Institute, Westmead Hospital, University of Sydney, Australia.
  • Reitsamer R; Breast Center Salzburg, University Clinic Salzburg, Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Koller R; Department of Plastic, Aesthetic and Reconstructive Surgery, Vienna Health Services, Clinic Landstrasse and Clinic Ottakring, Vienna, Austria.
  • Schrenk P; Breast Cancer Center, Kepler University Hospital, Linz, Austria.
  • Kauer-Dorner D; Department of Radiooncology, University Hospital Vienna, Austria.
  • Biazus J; Division of Breast Surgery, Universidade Federal Do Rio Grande Do Sul (UFRGS), Porto Alegre, Brazil.
  • Brenelli F; Breast Oncology Division, University of Campinas, Campinas, São Paulo, Brazil.
  • Letzkus J; San Borja Arriaran Clinical Hospital, University of Chile, Chile.
  • Saccilotto R; University of Basel, Basel, Switzerland.
  • Joukainen S; Kuopio University Hospital, Kuopio, Finland.
  • Kauhanen S; Department of Plastic Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Karhunen-Enckell U; Tampere University Hospital, Department of Surgery and Tays Cancer Center, Tampere, Finland.
  • Hoffmann J; Breast Center, University Hospital Düsseldorf, Düsseldorf, Germany.
  • Kneser U; Department of Hand, Plastic and Reconstructive Surgery - Burn Center, BG Trauma Center Ludwigshafen/Rhine, Hand and Plastic Surgery, University Heidelberg, Heidelberg, Germany.
  • Kühn T; Interdisciplinary Breast Center, Klinikum Esslingen, Germany.
  • Kontos M; National and Kapodistrian University of Athens, Greece.
  • Tampaki EC; Department of Plastic, Reconstructive Surgeryand Burn Unit, KAT Athens Hospital and Trauma Center, Athens, Greece.
  • Carmon M; Tel Aviv Soraski Medical Center, Israel.
Breast ; 63: 123-139, 2022 Jun.
Article en En | MEDLINE | ID: mdl-35366506
AIM: Demand for nipple- and skin- sparing mastectomy (NSM/SSM) with immediate breast reconstruction (BR) has increased at the same time as indications for post-mastectomy radiation therapy (PMRT) have broadened. The aim of the Oncoplastic Breast Consortium initiative was to address relevant questions arising with this clinically challenging scenario. METHODS: A large global panel of oncologic, oncoplastic and reconstructive breast surgeons, patient advocates and radiation oncologists developed recommendations for clinical practice in an iterative process based on the principles of Delphi methodology. RESULTS: The panel agreed that surgical technique for NSM/SSM should not be formally modified when PMRT is planned with preference for autologous over implant-based BR due to lower risk of long-term complications and support for immediate and delayed-immediate reconstructive approaches. Nevertheless, it was strongly believed that PMRT is not an absolute contraindication for implant-based or other types of BR, but no specific recommendations regarding implant positioning, use of mesh or timing were made due to absence of high-quality evidence. The panel endorsed use of patient-reported outcomes in clinical practice. It was acknowledged that the shape and size of reconstructed breasts can hinder radiotherapy planning and attention to details of PMRT techniques is important in determining aesthetic outcomes after immediate BR. CONCLUSIONS: The panel endorsed the need for prospective, ideally randomised phase III studies and for surgical and radiation oncology teams to work together for determination of optimal sequencing and techniques for PMRT for each patient in the context of BR.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Mamoplastia Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Breast Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Mamoplastia Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Breast Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article